Local Institution
				
				
					1 Hollow Lane					
New Hyde Park, New York 11042
														
          New Hyde Park, New York 11042
We've found
        1 trials
        at this facility
      	
	Hodgkin Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	